BBB |
Blood-brain barrier |
CAR |
Chimeric antigen receptor |
CB |
Cord blood |
CSF |
Cerebrospinal fluid |
CNS |
Central Nervous System |
CTL |
Cytotoxic T lymphocyte |
CVO |
Circumventricular organ |
ECM |
Extracellular matrix |
EGF |
Epidermal growth factor |
EGFR |
Epidermal growth factor receptor |
DISC |
Death-inducing signaling complex |
DNRII |
Dominant negative TGF-β receptor II |
FADD |
Fas-associated death receptor |
FasL |
Fas-ligand |
GB |
glioblastoma |
HDACi |
Histone deacetylase inhibitor |
HLA |
Human leukocyte antigen |
IL |
Interleukin |
ITAM |
Immunoreceptor tyrosine-based activation motif |
ITIM |
Immunoreceptor tyrosine-based inhibition motif |
ITSM |
Immunoreceptor tyrosine-based switch motif |
ITT |
Immunoreceptor tyrosine tail |
KIR |
Killer immunoglobulin-like receptor |
LAK |
Lymphokine-activated killer |
MHC |
Major histocompatibility complex |
MICA |
MHC class I polypeptide-related sequence A |
MMP |
matrix metalloproteinase |
MTOC |
Microtubule-organizing center |
NK |
Natural Killer |
PBMC |
Peripheral blood mononuclear cell |
PDGF |
Platelet-derived growth factor |
PDGFR |
Platelet-derived growth factor receptor beta |
PGE2 |
Prostaglandin E2 |
SHP-1 |
Src homology region 2 domain-containing phosphatase-1 |
TAM |
Tumor-associated macrophage |
TCR |
T-Cell receptor |
TGF-β |
Transforming Growth Factor beta |
TMZ |
Temozolomide |
TRAIL |
Tumor necrosis factor-related apoptosis-induced ligand |
Treg |
Tregulatory lymphocyte |
VEGF |
Vascular endothelial growth factor |